USPTO 2015–2025 USPTO PatentsView US Corporation

Bio-rad Laboratories, Inc.

USPTO PatentsView assignee record - 597 granted patents across 82 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: G01N (INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES).

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Explore the portfolio See the ranking

597

Total patents granted

CPC technology areas

16.8

Avg claims per patent

+4%

5-year filing velocity

The verdict

Bio-rad holds 597 US patents across 82 technology areas, rank #767 of 50,000 tracked assignees.

#767
of 50,000 US assignees by volume: Top 3%
by Innovation Score (61.6/100): 16.8
avg claims per patent: +4%
filing velocity, last 5 yrs

Portfolio overview

Bio-rad Laboratories, Inc. has been granted 597 US utility patents between 2015 and 2025, placing Bio-rad Laboratories, Inc. at rank #767 across all assignees tracked by PlainPatent. This portfolio spans 82 distinct Cooperative Patent Classification (CPC) subclasses, averaging 16.8 claims per patent with primary concentration in G01N (INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES). As a US Corporation, Bio-rad Laboratories, Inc. is one of the broader-portfolio assignees in the PatentsView dataset. By volume, Bio-rad sits between Ethicon Endo-surgery, Inc. (601 patents, rank #763) and Red Hat Israel Ltd. (594 patents, rank #771) - the closest US assignees by grant volume. The composite Innovation Score of 61.6/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 304 grants, compared with 293 in the 2015–2019 window, a +4% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Bio-rad Laboratories, Inc.'s 16.8 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 82 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Bio-rad Laboratories, Inc. against peers pursuing similar technology classes.

Ethicon Endo-surg…

601
Sunpower

601
Vitesco

601
TDK Taiwan

598
Donaldson

597
Panasonic Liquid…

597
Bio-rad Laborator… ◀

597
Hunter Fan

594
Red Hat Israel

594

What this shows Bio-rad holds 597 patents at rank #767, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Bio-rad

By rank, the assignees closest to #767 in granted patent volume.

Leaders in G01N (Investigating OR Analysing Materials BY Determining Their…)

Other assignees with the most granted patents in Bio-rad's primary technology class.

Bio-rad's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

62 Top 3% higher than 97% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Bio-rad Laboratories, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	46	7.7%
2016	55	9.2%
2017	73	12.2%
2018	66	11.1%
2019	53	8.9%
2020	79	13.2%
2021	62	10.4%
2022	34	5.7%
2023	42	7.0%
2024	53	8.9%
2025	34	5.7%

Which technologies does Bio-rad Laboratories, Inc. patent most?

G01N - INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 313

C12Q - MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES 248

B01L - CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE 174

C12N - MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA 104

C07K - PEPTIDES 76

B01F - MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING 72

B01J - CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS 58

B01D - SEPARATION 53

Y10T - TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION 53

C12Y - ENZYMES 38

G02B - OPTICAL ELEMENTS, SYSTEMS OR APPARATUS 29

C40B - COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES 28

C12M - APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS 26

C12P - FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 21

G06V - IMAGE OR VIDEO RECOGNITION OR UNDERSTANDING 18

Top 15 of 82 technology areas

Patent Moat Analysis

Portfolio Volume Moderate

Tech Breadth Multi-domain

Claim Depth Standard

Velocity Growing

Where it ranks

Overall rank by patents

#767

Across all tracked assignees

Innovation Score

61.6 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Bio-rad Laboratories, Inc. hold?

Bio-rad Laboratories, Inc. holds 597 US granted patents filed between 2015 and 2025, spanning 82 technology areas.

What is Bio-rad Laboratories, Inc.'s Innovation Score?

Bio-rad Laboratories, Inc. has an Innovation Score of 61.6 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Bio-rad Laboratories, Inc. focus on?

Bio-rad Laboratories, Inc.'s top technology area is G01N (INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES) with 313 patents. The company has filed patents in 82 CPC subclasses total.

Is Bio-rad Laboratories, Inc.'s patent filing rate increasing or decreasing?

Bio-rad Laboratories, Inc.'s recent filing velocity is +4% compared to the prior five-year period. The company is maintaining or growing its patent output.

What does claim depth mean for Bio-rad Laboratories, Inc.'s patents?

Bio-rad Laboratories, Inc.'s patents average 16.8 claims each. This falls within the standard range, providing solid legal coverage.

How is the Bio-rad Laboratories, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Bio-rad's 597 grants land it in the top 3% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - Bio-rad ranks #767 of 50,000. Top 50 holders
Most of this portfolio concentrates in G01N - see who else leads that technology area. G01N leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.